Ninlaro (Ixazomib) 2.3mg/3mg/4mg Capsules | Oral Proteasome Inhibitor | Takeda Japan | GLT

Generic Information: Ninlaro (Ixazomib) — Takeda Japan

Ninlaro is the brand name for ixazomib, the first oral proteasome inhibitor to reach the market. Developed by Takeda Pharmaceutical Company Limited in Japan, it broke new ground by letting patients take a proteasome inhibitor as a capsule at home instead of an injection or infusion in a clinic. The Japanese-marketed Ninlaro is supplied in three capsule strengths — 2.3 mg, 3 mg and 4 mg — which makes dose adjustment straightforward as treatment progresses.

What Is Ninlaro (Ixazomib) Used For?

Ninlaro is prescribed for adults with multiple myeloma, a malignancy of the antibody-producing plasma cells that live in the bone marrow. In practice it is given as part of a three-drug combination:

• Together with lenalidomide and dexamethasone — for patients whose myeloma has come back or stopped responding after at least one earlier line of treatment.
• As an all-oral regimen that removes the need for regular infusion-centre visits, a meaningful change for people who live far from a hospital.

How Does Ninlaro (Ixazomib) Work?

Ixazomib belongs to a class called proteasome inhibitors. Every cell contains proteasomes — barrel-shaped complexes that shred worn-out or misfolded proteins so the cell can reuse the building blocks. Myeloma cells churn out huge amounts of antibody protein and lean heavily on this recycling machinery to survive. Ixazomib plugs the β5 subunit of the 20S proteasome, but only reversibly. The result is a build-up of damaged proteins inside the malignant plasma cell, which sets off stress signals and eventually drives the cell into apoptosis. Normal cells tolerate the blockade far better, which is why the drug is selective enough for routine clinical use.

Indications

• Relapsed or refractory multiple myeloma — combined with lenalidomide and dexamethasone after at least one prior therapy.

Dosage & Administration

The usual Ninlaro starting dose is 4 mg by mouth once a week, taken on days 1, 8 and 15 of each 28-day cycle. Capsules should be swallowed whole with a glass of water at about the same time every dosing day, either one hour before or two hours after eating. Because the 2.3 mg and 3 mg strengths exist, your haematologist can step the dose down smoothly if blood counts or nerve symptoms require it.

Side Effects

Across the registration trials the adverse events seen most often (in roughly one in five patients or more) were diarrhoea, constipation, thrombocytopenia, peripheral neuropathy, nausea, peripheral oedema, vomiting and back pain. The side effects that most need watching are low platelets, gut toxicity, nerve damage and fluid retention. Routine blood counts are part of every cycle. Tell your doctor about any numbness or tingling in the hands or feet early, since the dose can usually be adjusted before it becomes troublesome.

Storage & Handling

Keep Ninlaro capsules in their original blister at room temperature, no warmer than 30 °C. Do not refrigerate or freeze them. Store the pack where children cannot reach it and check the expiry date before use.

Why Choose Ninlaro (Ixazomib) from Takeda Japan?

• A true first-in-class medicine — Ninlaro was the first oral proteasome inhibitor, and it remains the reference against which later oral versions are measured.
• Three capsule strengths — the 2.3/3/4 mg range gives your doctor fine control over dosing.
• Takeda's Japanese originator quality — manufactured to global GMP standards under the company that discovered the molecule.
• GLT supply chain — GIVE LIFE TIME LIMITED ships batch-traceable Ninlaro with complete documentation worldwide.

How to Order Ninlaro (Ixazomib) from GLT?

1. Send your enquiry by WhatsApp +86 15234153837 or email [email protected], stating the strength and quantity you need.
2. GLT returns a formal quotation, payment details and a delivery estimate.
3. Pay through our secured channel (Hao Yi Lian / 好易联).
4. Your order ships with batch records and tracking until it reaches you.

We supply hospitals, pharmacies, importers and individual patients. A valid prescription may be required before dispatch.

FAQ

1. Is Ninlaro (ixazomib) the same everywhere?

Yes — Ninlaro is the same Takeda ixazomib product, though the available capsule strengths and packaging differ slightly by country. GLT can source the Japanese-market version with 2.3/3/4 mg capsules.

2. What is the price of Ninlaro (ixazomib)?

Pricing depends on strength, quantity and destination. Contact GLT for a current quotation — batch-traceable originator supply is provided with full documentation.

3. How is Ninlaro different from generic ixazomib?

Ninlaro is the original Takeda product; generics contain the same ixazomib active ingredient but are made by other manufacturers. GLT offers both.

4. Can I take Ninlaro at home?

Yes. Ninlaro is taken as an oral capsule once weekly, so most patients manage their treatment at home without infusion visits.

5. Does Ninlaro require a prescription?

Yes. Ixazomib is a prescription medicine, and a valid prescription may be requested before GLT dispatches your order.